Diabetic Macular Edema, Non-Proliferative Diabetic Retinopathy, Type 2 Diabetes Mellitus
Conditions
Brief summary
In Type 2 Diabetes mellitus patients we will: 1. quantify vasculopathy and blood-retinal barrier (BRB) leakage 2. measure blood-brain barrier (BBB) permeability and neuroanatomical changes 3. correlate BRB pathology with BBB breakdown, inflammatory markers and neuropsychiatric sequela
Interventions
None listed
Sponsors
Soroka University Medical Center
Study design
Observational model
COHORT
Eligibility
Sex/Gender
ALL
Age
18 Years to 75 Years
Healthy volunteers
No
Inclusion criteria
1. T2DM Patient suffering from Non-Proliferative Diabetic Retinopathy (NPDR), Proliferative Diabetic Retinopathy (PDR) and Diabetic Macular Edema (DME) who are in the clinical database of the ophthalmologic department , above 18 years old at the time of diagnosis and underwent FA examination in the past three years 2. Patients which their medical records are available via a computerized data base Control group: 1. T2DM patients who are in the clinical database of the ophthalmologic department 2. Above 18 years old at the time of diagnosis 3. Underwent FA examination in the past three years and their examination was interpreted as normal, i.e. without suspected diabetic retinopathy
Countries
Israel
Contacts
Primary ContactHadar Shalev, M.D
Outcome results
None listed